| Long name | APOC3 Primary Polyclonal Antibody |
| Also known as | APOC3 PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | APOC3 |
| Specificity | This is a highly specific antibody against APOC3 |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Immunogen range | 27-47/99 |
| Subcellular location | Secreted |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human APOC3 |
| Gene ID number | 6347 |
| Swiss Prot | P13500 |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Augments monocyte anti-tumor activity, Has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis, like psoriasis, rheumatoid arthritis or atherosclerosis, Chemotactic factor that attracts monocytes and basophils but not neutrophils or eosinophils |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | C-C motif chemokine 2, CCL2, GDCF-2, HSMCR30, MCAF, MCP-1, MCP1, Monocyte chemoattractant protein 1, Monocyte chemotactic and activating factor, Monocyte chemotactic protein 1, Monocyte secretory protein JE, SCYA2, SMC-CF, Small-inducible cytokine A2, HC11 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | APOC3 |
| Short name | APOC3 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | apolipoprotein C-III (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | APOC3 and IDBG-630792 and ENSBTAG00000012398 and 408009, APOC3 and IDBG-72562 and ENSG00000110245 and 345, APOCIII and HALP2, Apoc3 and IDBG-161220 and ENSMUSG00000032081 and 11814, Extracellular, high-density lipoprotein particle receptor binding, this GO :0001523 and retinoid metabolic process and biological process this GO :0005543 and phospholipid binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005769 and early endosome and cellular component this GO :0006641 and triglyceride metabolic process and biological process this GO :0006642 and triglyceride mobilization and biological process this GO :0006869 and lipid transport and biological process this GO :0006954 and inflammatory response and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0007584 and response to nutrient and biological process this GO :0007603 and phototransduction, this GO :0005543: phospholipid binding, this GO :0005543: phospholipid binding and also this GO :0008289: lipid binding and also this GO :0015485: cholesterol binding and also this GO :0030234: enzyme regulator activity and also this GO :0055102: lipase inhibitor activity and also this GO :0070653: high-density lipoprotein particle receptor binding, this GO :0008289: lipid binding, this GO :0015485: cholesterol binding, this GO :0030234: enzyme regulator activity, this GO :0055102: lipase inhibitor activity, this GO :0070653: high-density lipoprotein particle receptor binding, visible light and biological process this GO :0008203 and cholesterol metabolic process and biological process this GO :0008289 and lipid binding and molecular function this GO :0010897 and negative regulation of triglyceride catabolic process and biological process this GO :0010903 and negative regulation of very-low-density lipoprotein particle remodeling and biological process this GO :0010916 and negative regulation of very-low-density lipoprotein particle clearance and biological process this GO :0010987 and negative regulation of high-density lipoprotein particle clearance and biological process this GO :0010989 and negative regulation of low-density lipoprotein particle clearance and biological process this GO :0015485 and cholesterol binding and molecular function this GO :0019433 and triglyceride catabolic process and biological process this GO :0030234 and enzyme regulator activity and molecular function this GO :0032489 and regulation of Cdc42 protein signal transduction and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034363 and intermediate-density lipoprotein particle and cellular component this GO :0034366 and spherical high-density lipoprotein particle and cellular component this GO :0034375 and high-density lipoprotein particle remodeling and biological process this GO :0034379 and very-low-density lipoprotein particle assembly and biological process this GO :0034382 and chylomicron remnant clearance and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042493 and response to drug and biological process this GO :0042627 and chylomicron and cellular component this GO :0042632 and cholesterol homeostasis and biological process this GO :0042953 and lipoprotein transport and biological process this GO :0043434 and response to peptide hormone and biological process this GO :0043691 and reverse cholesterol transport and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045717 and negative regulation of fatty acid biosynthetic process and biological process this GO :0045833 and negative regulation of lipid metabolic process and biological process this GO :0048261 and negative regulation of receptor-mediated endocytosis and biological process this GO :0050995 and negative regulation of lipid catabolic process and biological process this GO :0051005 and negative regulation of lipoprotein lipase activity and biological process this GO :0055102 and lipase inhibitor activity and molecular function this GO :0060621 and negative regulation of cholesterol import and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070328 and triglyceride homeostasis and biological process this GO :0070653 and high-density lipoprotein particle receptor binding and molecular function this GO :0071333 and cellular response to glucose stimulus and biological process, apolipoprotein C-III |
| Identity | 610 |
| Gene | APOC3 |
| Long gene name | apolipoprotein C3 |
| Synonyms gene name | apolipoprotein C-III |
| Locus | 11q23, 3 |
| Discovery year | 2001-06-22 |
| GenBank acession | X01388 |
| Entrez gene record | 345 |
| RefSeq identity | NM_000040 |
| Classification | Apolipoproteins |
| Havana BLAST/BLAT | OTTHUMG00000046115 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue